MAP2K7 and brain cancer: Figure 4A illustrates the level of the GADD45β/CDC2 complex by Co‐IP and the immunoblotting results of cellular proteins in CuE‐treated brain cancer cell lines with or without DTP3 (GADD45β/MKK7 inhibitor).